Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

McKesson Corp (NY: MCK )

582.65 +2.52 (+0.44%)
Streaming Delayed Price Updated: 3:23 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about McKesson Corp

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
McKesson Posts Better Than Expected Q2 Earnings; Raises FY22 EPS Outlook Again
McKesson Corp (NYSE: MCK) reported second-quarter FY22 adjusted EPS of $6.15, +28% Y/Y, and easily beating the analyst consensus of $4.66. Revenues increased 9% Y/Y to... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Edge Lower; Fed Meeting In Focus
Pre-open movers U.S. stock futures traded slightly lower in early pre-market trade after settling at record highs in the previous session. The Federal Open Market Committee will... 
Via Benzinga
Topics Economy
Exposures Interest Rates
5 Stocks To Watch For November 2, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Pfizer Inc. (NYSE: PFE) to report quarterly earnings at $1.08 per share on revenue of $22.41... 
Via Benzinga
McKesson Corporation (MCK) Q2 2022 Earnings Call Transcript
MCK earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Biophytis (NASDAQ:BPTS) shares mo... 
Via Benzinga
Unusual Options Activity Insight: McKesson
Shares of McKesson (NYSE:MCK) saw some unusual options activ... 
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new... 
Via Benzinga
How Bad Are McKesson's Earnings? | Return On Capital Employed
According to Benzinga Pro data McKesson (NYSE:MCK) posted a 57.74% decrease in earnings from Q4. Sales, however, increased by 5.97% over the previous quarter to $62.67 billion.... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Manufacturing Data
Pre-open movers U.S. stock futures traded higher in early pre-market trade after closing at record highs in the previous session. Investors are awaiting earnings results from PG... 
Via Benzinga
5 Stocks To Watch For November 1, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects PG&E Corporation (NYSE: PCG) to report quarterly earnings at $0.26 per share on revenue of $5... 
Via Benzinga
Cannabis Movers & Shakers: Dosist, Lantern, Hollister, Ascend Wellness, Volunteer Botanicals
Dosist Appoints Marie Dacyshyn As President & CMO Dosist chief marketing officer Anne Marie Dacyshyn has been 
Via Benzinga
Topics Cannabis
Exposures Cannabis
11 Dividend Contenders For Growth And Income
Despite the general high valuation of the overall market, these research candidates are currently sound and attractive. 
Via Talk Markets
Earnings Scheduled For November 1, 2021
Companies Reporting Before The Bell • ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter. • Kiniksa Pharmaceuticals (NASDAQ:... 
Via Benzinga
Drug Distributors Ink First Opioid Settlement With Cherokee Nation
Cardinal Health Inc (NYSE: CAH), McKesson Corporation (NYSE: MCK), and AmerisourceBergen Corp (NYSE: ABC), accused of U.S. addiction crisis, have... 
Via Benzinga
Mckesson Stock Shows Rising Relative Strength; Still Shy Of Key Threshold
A Relative Strength Rating upgrade for Mckesson shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Endo Shares Move Higher On Settlement Of New York State Opioid Cases
Endo International plc (NASDAQ: ENDP) has agreed to pay $50 million to resolve lawsuits by New York state and two of its largest counties related to the sale and... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
McKesson Q1 Earnings Surpass Wall Street Estimate; Raises FY22 EPS Outlook
McKesson Corp (NYSE: MCK) reported first-quarter FY22 adjusted EPS of $5.56, almost doubled from $2.77 a year ago, and easily beating the analyst consensus of $4.17.... 
Via Benzinga
McKesson Corporation (MCK) Q1 2022 Earnings Call Transcript
MCK earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: McKesson Q1 Earnings
Shares of McKesson (NYSE:MCK) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 100.72% year over year to $5.56,... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Mostly lower Ahead Of General Motors Earnings
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade after the Dow Jones surged around 280 points in the previous session. Investors are awaiting... 
Via Benzinga
Topics Stocks
Exposures US Equities
5 Stocks To Watch For August 4, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects General Motors Company (NYSE: GM) to report quarterly earnings at $1.34 per share on revenue of $... 
Via Benzinga
Another Whopping 12.9%? This Dividend King Has Been Raising Its Dividend For 55 Consecutive Years
Dividend growth investing; it's the gift that keeps on giving. But it's better than that, because the gifts -- the dividends -- get bigger and bigger. 
Via Talk Markets
Drug Distributors To Pay Up To $1.1B To Settle New York Opioid Claims
McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) have agreed to pay up to $1.179 billion... 
Via Benzinga
Drug Stocks McKesson, AmerisourceBergen Pop On Reports Of $26 Billion Settlement In Opioid Fight
Drug stocks popped Tuesday on reports they could pay $21 billion to settle claims they helped fuel the nation's opioid epidemic. 
Via Investor's Business Daily
Topics Lawsuit
Exposures Financial Legal
Opioid Settlement Of $26B Between Drug Companies, States To Potentially Conclude This Week
U.S. states attorneys general are expected to conclude the $26B settlement with three drug distributors and Johnson & Johnson (NYSE: JNJ) this week... 
Via Benzinga
New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid
Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly... 
Via Benzinga
JNJ's $260M Settlement Could Serve As Global Opioid Deal Template: Analyst
Over the weekend, Johnson & Johnson (NYSE:JNJ) reached a ... 
Via Benzinga
Johnson & Johnson Reaches $230M Settlement With New York To End Sale Of Opioids Nationwide
The company has said that it has not marketed opioids in the U.S. since 2015 and discontinued the business in 2020. JNJ did not admit liability in settling with New York State, Nassau, and Suffolk... 
Via Talk Markets
Johnson & Johnson Reaches $230M Settlement With New York State To End Sale Of Opioids Nationwide
On Saturday, Johnson & Johnson (NYSE: JNJ) said it would end the manufacture and sale of opioids nationwide in a $230 million settlement with the New York state,... 
Via Benzinga
Mirion Technologies Gets SPAC Deal With GSAH: What Investors Should Know
Mirion Technologies, a leader in the radiation hardware, software and alignment for hospitals, urgent care clinics, dental offices, veterinary offices and nuclear... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.